Exact Sciences Corp (EXAS)

21.08
NASDAQ : Health Care
Prev Close 20.49
Day Low/High 20.32 / 21.33
52 Wk Low/High 5.36 / 24.50
Avg Volume 2.79M
Exchange NASDAQ
Shares Outstanding 110.60M
Market Cap 2.27B
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.

Exact Sciences And Mayo Clinic Study Shows Promise Of New Blood-based Lung Cancer Test

Exact Sciences And Mayo Clinic Study Shows Promise Of New Blood-based Lung Cancer Test

AACR abstract highlights methylation markers capable of detecting all types of lung cancer with more than 90% sensitivity and specificity

T-Mobile, Verizon, Kellogg, Box, Best Buy : 'Mad Money' Lightning Round

T-Mobile, Verizon, Kellogg, Box, Best Buy : 'Mad Money' Lightning Round

Jim Cramer is bullish on T-Mobile, Box and Treehouse Foods. He's bearish on Verizon and Best Buy.

Don't Give Trump All the Credit for Market Gains: Cramer's 'Mad Money' Recap (Thursday 2/23/17)

Don't Give Trump All the Credit for Market Gains: Cramer's 'Mad Money' Recap (Thursday 2/23/17)

Jim Cramer knows this administration is pro-business, but Washington isn't the only place building business and market strength.

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Here are Wednesday's top research calls, including downgrades for Discovery, First Solar and Momenta, and an upgrade for VF Corp.

CMS Proposes Inclusion Of Cologuard In Medicare Advantage Star Ratings

CMS Proposes Inclusion Of Cologuard In Medicare Advantage Star Ratings

Cologuard offers health plans an opportunity to increase screening & improve quality ratings

Nasdaq Separates Itself From the Rest of the Market

Nasdaq Separates Itself From the Rest of the Market

Narrowing strength becomes a concern.

Major Indices' Support Holds, But Momentum Eases

Major Indices' Support Holds, But Momentum Eases

Biotech shares have gained from takeovers in that sector.

Exact Sciences To Report $99 Million In Revenues, 150 Percent Growth For 2016

Exact Sciences To Report $99 Million In Revenues, 150 Percent Growth For 2016

- Preliminary revenues between $99.0 million and $99.5 million for 2016, a year-over-year increase of 150 percent;

Cologuard Earns Positive Review From Blue Cross Blue Shield Association

Cologuard Earns Positive Review From Blue Cross Blue Shield Association

Cologuard Covered for 70 Percent of Addressable Population

Cologuard Available To Humana Members As In-Network Colon Cancer Screening Option

Cologuard Available To Humana Members As In-Network Colon Cancer Screening Option

Members of Fifth Largest Commercial Insurer will have Access to Non-Invasive Colon Cancer Screening Test and Compliance Service

Exact Sciences Appoints Jeff Elliott Chief Financial Officer

Exact Sciences Appoints Jeff Elliott Chief Financial Officer

Respected diagnostics industry expert will help lead efforts to capitalize on market opportunity for Cologuard

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.

Cologuard® Covered For TRICARE Beneficiaries

Cologuard® Covered For TRICARE Beneficiaries

America's veterans, military personnel and their families provided access to non-invasive, at-home colon cancer screening option without copay

Exact Sciences (EXAS) Stock Climbs, Colorectal Cancer Screening Guidelines Updated

Exact Sciences (EXAS) Stock Climbs, Colorectal Cancer Screening Guidelines Updated

Exact Sciences (EXAS) stock is gaining on Monday after the National Committee for Quality Assurance updated its guidelines on colorectal cancer screening tests.

Exact Sciences Announces Inclusion Of Cologuard® In HEDIS Quality Measures

Exact Sciences Announces Inclusion Of Cologuard® In HEDIS Quality Measures

Cologuard offers opportunity for health plans, systems & providers to improve quality ratings

2 Bullish Stock Picks and 2 Stocks to Sell Short

2 Bullish Stock Picks and 2 Stocks to Sell Short

Here's a look at two stocks that are trending higher and two that are ripe for short-selling.

EXAS: Insiders vs. Shorts

EXAS: Insiders vs. Shorts

The most recent short interest data was recently released for the 08/31/2016 settlement date, and EXACT Sciences Corp. is one of the most shorted stocks of the Russell 3000, based on 8.37 "days to cover" versus the median component at 6.39.

4 Breakout Stocks to Watch

4 Breakout Stocks to Watch

These four stocks are looking strong technically, either breaking out or approaching breakout levels.